Doxorubicin Hydrochloride Injectable, Liposomal
Product Images NDC 68001-345

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 68001-345). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hspc (Hspc)

Chemical structure diagram of Doxorubicin Hydrochloride liposomal active ingredient, showing phosphate and lipid components in a detailed molecular format.*

FDA Label Image

Mpeg (Mpeg)

Chemical structure of Doxorubicin Hydrochloride injectable liposomal 2 mg/mL, showing the molecular arrangement including phospholipid components typical of liposomal formulations.*

FDA Label Image

Peglyated (Peglyated)

An illustration diagram showing the structure of liposomal doxorubicin hydrochloride. The diagram labels the aqueous core containing entrapped doxorubicin HCl, the surrounding liposomal bilayer, and the outer MPEG-DSPE coating.*

FDA Label Image

Graph (Graph)

A survival curve chart showing the percent of subjects progression-free over time in months. It compares two treatment groups: Doxorubicin HCl plus Bortezomib versus Bortezomib alone. The chart includes a p-value and hazard ratio indicating statistical analysis results. Censored data points are marked with plus signs.*

FDA Label Image

Doxorubicin HCl Liposome Inj 20mg_10ml Label (Image 01)

Label for Doxorubicin Hydrochloride Liposome Injection 20 mg/10 mL (2 mg/mL) injectable solution by BluePoint Laboratories. The label includes storage instructions (refrigerate 2°-8°C, do not freeze), dosage note to see package insert, and a caution that this liposomal formulation should not be substituted for regular Doxorubicin HCl. It also states it is for intravenous infusion only and comes in single-dose vials.*

FDA Label Image

Doxorubicin HCl 20mg/10ml Carton Rev 1219 (Image 02)

Packaging label for Doxorubicin Hydrochloride Liposome Injection 20 mg/10 mL (2 mg/mL) injectable liposomal formulation by BluePoint Laboratories. The label indicates it is for intravenous infusion only, single-dose vial, cytotoxic agent, and storage at 2°-8°C (36°-46°F). Includes warnings not to substitute for doxorubicin HCl and instructions to discard unused portions.*

FDA Label Image

Doxorubicin HCl Liposome Inj 50mg_25ml Label (Image 03)

Label for Doxorubicin Hydrochloride Liposome Injection 2 mg/mL (50 mg/25 mL) by BluePoint Laboratories. It states the product is a cytotoxic agent for intravenous infusion only, must be diluted, and refrigerated at 2°-8°C without freezing. The label includes a barcode, manufacturer details (Natco Pharma Ltd, India), and highlights the liposomal formulation with a warning not to substitute for doxorubicin HCl.*

FDA Label Image

Doxorubicin HCl 50mg/25ml Carton Rev 1219 (Image 04)

Packaging label for Doxorubicin Hydrochloride Liposome Injection, 2 mg/mL (50 mg/25 mL) injectable liposomal formulation by BluePoint Laboratories. The label states it is for intravenous infusion only, single-dose vial, cytotoxic agent, with storage instructions to refrigerate at 2°-8°C and not to freeze. It also emphasizes that it is a liposomal formulation and should not be substituted for doxorubicin HCl.*

FDA Label Image

Stru (Stru)

Chemical structure of doxorubicin hydrochloride, showing its molecular components including ring structures, hydroxyl groups, and amine groups, with hydrochloride (HCl) indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.